Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Acura Pharmaceuticals Current Ratio 2010-2021 | ACUR

Acura Pharmaceuticals current ratio from 2010 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
Acura Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-12-31 $0.00B $0.00B 0.72
2021-09-30 $0.00B $0.00B 0.86
2021-06-30 $0.00B $0.00B 1.18
2021-03-31 $0.00B $0.01B 0.18
2020-12-31 $0.00B $0.01B 0.16
2020-09-30 $0.00B $0.00B 1.37
2020-06-30 $0.00B $0.01B 0.26
2020-03-31 $0.00B $0.01B 0.19
2019-12-31 $0.00B $0.00B 1.10
2019-09-30 $0.00B $0.00B 0.80
2019-06-30 $0.00B $0.00B 0.56
2019-03-31 $0.00B $0.01B 0.05
2018-12-31 $0.00B $0.00B 0.32
2018-09-30 $0.00B $0.00B 0.12
2018-06-30 $0.00B $0.00B 0.23
2018-03-31 $0.00B $0.00B 0.24
2017-12-31 $0.00B $0.01B 0.55
2017-09-30 $0.01B $0.00B 1.23
2017-06-30 $0.00B $0.00B 0.93
2017-03-31 $0.01B $0.00B 1.53
2016-12-31 $0.01B $0.00B 1.70
2016-09-30 $0.01B $0.00B 1.26
2016-06-30 $0.01B $0.00B 1.95
2016-03-31 $0.01B $0.00B 2.63
2015-12-31 $0.01B $0.00B 4.36
2015-09-30 $0.02B $0.00B 4.18
2015-06-30 $0.01B $0.00B 3.10
2015-03-31 $0.02B $0.00B 3.98
2014-12-31 $0.01B $0.00B 4.42
2014-09-30 $0.02B $0.00B 5.32
2014-06-30 $0.02B $0.00B 7.87
2014-03-31 $0.02B $0.00B 14.43
2013-12-31 $0.03B $0.00B 24.80
2013-09-30 $0.02B $0.00B 18.69
2013-06-30 $0.02B $0.00B 19.04
2013-03-31 $0.02B $0.00B 11.14
2012-12-31 $0.03B $0.00B 19.66
2012-09-30 $0.03B $0.00B 43.43
2012-06-30 $0.03B $0.00B 35.51
2012-03-31 $0.03B $0.00B 35.81
2011-12-31 $0.04B $0.00B 68.17
2011-09-30 $0.04B $0.00B 34.13
2011-06-30 $0.04B $0.00B 32.52
2011-03-31 $0.02B $0.00B 22.43
2010-12-31 $0.02B $0.00B 21.22
2010-09-30 $0.03B $0.00B 19.91
2010-06-30 $0.03B $0.00B 18.45
2010-03-31 $0.03B $0.00B 14.52
2009-12-31 $0.03B $0.00B 15.33
2009-09-30 $0.03B $0.00B 11.70
2009-06-30 $0.04B $0.00B 9.37
2009-03-31 $0.04B $0.00B 9.21
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.303B 6.73
Dr Reddy's Laboratories (RDY) India $11.772B 21.36
BridgeBio Pharma (BBIO) United States $8.662B 0.00
Bausch Health Cos (BHC) Canada $2.365B 1.70
Supernus Pharmaceuticals (SUPN) United States $1.879B 15.26
Amphastar Pharmaceuticals (AMPH) United States $1.006B 6.75
Taysha Gene Therapies (TSHA) United States $0.588B 0.00
Personalis (PSNL) United States $0.494B 0.00
Assembly Biosciences (ASMB) United States $0.137B 0.00
Sol-Gel Technologies (SLGL) Israel $0.035B 0.00
Evoke Pharma (EVOK) United States $0.006B 0.00
Teligent (TLGT) United States $0.000B 0.00